LeuTech imaging agent:Phase III trials

Palatin Technologies Inc. (PLTN), Princeton, N.J. Product: LeuTech imaging agent Indication: Diagnose equivocal appendicitis Status: PLTN began U.S. Phase III trials of LeuTech in 200 patients. ...